MoneyWorks4Me

Bharat Parenterals - Quaterly Results

09 Feb 2022 Evaluate
The sales slipped to Rs. 384.60 millions for the December 2021 quarter as against Rs. 495.50 millions during the year-ago period.Profit after Tax for the quarter ended December 2021 saw a decline of -73.01% from Rs. 54.10 millions to Rs. 14.60  millions.A decline of 42.10 millions was observed in the OP in the quarter ended December 2021 from 82.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 384.60 495.50 -22.38 1597.00 1630.40 -2.05 2036.70 2263.30 -10.01
Other Income 13.70 25.90 -47.10 56.50 71.40 -20.87 86.70 114.80 -24.48
PBIDT 42.10 82.50 -48.97 293.10 291.70 0.48 338.10 416.90 -18.90
Interest 2.10 1.70 23.53 6.50 3.70 75.68 7.60 8.60 -11.63
PBDT 40.00 80.80 -50.50 286.60 288.00 -0.49 330.50 408.30 -19.05
Depreciation 16.40 16.40 0.00 51.00 43.40 17.51 60.30 58.80 2.55
PBT 23.60 64.40 -63.35 235.60 244.60 -3.68 270.20 349.50 -22.69
TAX 9.00 10.30 -12.62 63.20 62.20 1.61 68.10 86.50 -21.27
Deferred Tax 0.80 -4.50 -117.78 -1.80 -1.50 20.00 -2.80 -11.70 -76.07
PAT 14.60 54.10 -73.01 172.40 182.40 -5.48 202.10 263.00 -23.16
Equity 57.30 57.30 0.00 57.30 57.30 0.00 57.30 57.30 0.00
PBIDTM(%) 10.95 16.65 -34.26 18.35 17.89 2.58 16.60 18.42 -9.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..